Since hypoxia is a key phenomenon in cancers [6], we tested whether DEK has a role in regulation of VEGF promoter activity and expression under hypoxic conditions using luciferase reporter assay, real-time reverse transcription-PCR (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). The gene discussed is VEGFA; the disease is cancer.